Sun Pharma, Tech Mahindra, Ramco Cements And More - Top Stock Picks For October: KRChoksey

BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy. .KRChoksey Research Report.Sun Pharmaceuticals Industries Ltd. - Sun Pharma has been experiencing healthy traction in the U.S. revenue over the last four quarters. Specialty business constitutes 30.0% of the U.S. and 13.8% of the overall revenue for Sun Pharma as of Q1 FY23. The specialty revenue growth has been impressive at an average of ~ 30.0% YoY over the last four quarters. The company has another four new drug application molecules undergoing trials. We continue to expect the company to post a 10.6% and 11.2% compound annual growth rate growth in its revenue and adjusted net income, respectively, over FY22-FY24E. Tech Mahindra Ltd. - In Q1 FY23, Ebitm stood at 11%, declined by 220 basis points QoQ due to a partial wage revision, lower utilisation, and a normalisation in selling, general and administration spend. Tech Mahindra has guided for 100-150 bps Ebit margin increase to 12-12.5% in Q2 FY22E. In spite of lower headwind from visa costs and removal of Comviva seasonality, benefit from rising contract pricing and higher utilisation rate are likely to aid to the margin. Ramco Cements Ltd. - For the last few quarters, Ramco has faced downward pressure on its margins due to sharp rise in the input cost, especially power and fuel and logistics costs. Ramco’s Ebitda margin stood at 26.6%, 14.7%, 17.2% and 17.0% respectively for Q2 FY22, Q3 FY22, Q4 FY22 and Q1 FY23. With crude prices now correcting significantly from its peak along with correction in pet coke and coal prices, Ramco is expected to improve its margin profile in the coming quarters..Click on the attachment to read the full report:.DISCLAIMERThis report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime..Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

Sun Pharma, Tech Mahindra, Ramco Cements And More - Top Stock Picks For October: KRChoksey

The investment period for stock picks is six months from the date of the recommendations provided.

Choose a plan